Inflammatory diseases: An IL-9 solution to inflammation resolution
Nature Reviews Drug Discovery 16, 600 (2017).
doi:10.1038/nrd.2017.164
Author: Megan Cully
Drugs for inflammation-driven diseases, such as rheumatoid arthritis, often aim to reduce the severity of the inflammatory response. Rauber et al. suggest an alternative strategy: promoting the resolution of inflammation. They found that IL-9 is needed for regulatory T (Treg) cells, which
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Megan Cully Tags: Research Highlight Source Type: research